NO20006520D0 - Adenosinderivater - Google Patents

Adenosinderivater

Info

Publication number: NO20006520D0
Authority: NO; Norway
Prior art keywords: adenosine
Prior art date: 1998-06-23

Application number

NO20006520A

Other languages

English (en)

Other versions

NO318788B1 (no

NO20006520L (no

Inventor

David Edmund Bays

Richard Peter Charles Cousins

Hazel Joan Dyke

Colin David Eldred

Brian David Judkins

Martin Pass

Andrew Michael Kenneth Pennell

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-23

Filing date

2000-12-20

Publication date

2000-12-20

2000-12-20 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2000-12-20 Publication of NO20006520D0 publication Critical patent/NO20006520D0/no

2001-02-14 Publication of NO20006520L publication Critical patent/NO20006520L/no

2005-05-09 Publication of NO318788B1 publication Critical patent/NO318788B1/no

Links

OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title 2
239000002126 C01EB10 - Adenosine Substances 0.000 title 1
229960005305 adenosine Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Hematology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)

NO20006520A 1998-06-23 2000-12-20 Adenosinderivater, samt fremgangsmate for fremstilling og anvendels derav og farmasoytisk preparat. NO318788B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9813554.4A GB9813554D0 (en)	1998-06-23	1998-06-23	Chemical compounds
PCT/EP1999/004182 WO1999067262A1 (en)	1998-06-23	1999-06-21	Adenosine derivatives

Publications (3)

Publication Number	Publication Date
NO20006520D0 true NO20006520D0 (no)	2000-12-20
NO20006520L NO20006520L (no)	2001-02-14
NO318788B1 NO318788B1 (no)	2005-05-09

Family

ID=10834247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20006520A NO318788B1 (no)	1998-06-23	2000-12-20	Adenosinderivater, samt fremgangsmate for fremstilling og anvendels derav og farmasoytisk preparat.

Country Status (39)

Country	Link
US (2)	US6492348B1 (no)
EP (2)	EP1090019B1 (no)
JP (2)	JP3378240B2 (no)
KR (1)	KR100612797B1 (no)
CN (2)	CN1616459A (no)
AP (1)	AP2000002014A0 (no)
AR (1)	AR018917A1 (no)
AT (1)	ATE277941T1 (no)
AU (1)	AU758018B2 (no)
BG (1)	BG65064B1 (no)
BR (1)	BR9911498A (no)
CA (1)	CA2335520C (no)
CO (1)	CO5040216A1 (no)
DE (1)	DE69920697T2 (no)
EA (1)	EA003828B1 (no)
EE (1)	EE04853B1 (no)
ES (1)	ES2226399T3 (no)
GB (1)	GB9813554D0 (no)
GE (1)	GEP20032958B (no)
HR (1)	HRP20000896B1 (no)
HU (1)	HUP0102453A3 (no)
ID (1)	ID27484A (no)
IL (2)	IL140284A0 (no)
IS (1)	IS5773A (no)
MY (1)	MY122481A (no)
NO (1)	NO318788B1 (no)
NZ (1)	NZ508915A (no)
OA (1)	OA11574A (no)
PE (1)	PE20000704A1 (no)
PL (1)	PL194087B1 (no)
PT (1)	PT1090019E (no)
RS (1)	RS50042B (no)
SI (1)	SI1090019T1 (no)
SK (1)	SK19582000A3 (no)
TR (1)	TR200100449T2 (no)
TW (1)	TW541312B (no)
UA (1)	UA64794C2 (no)
WO (1)	WO1999067262A1 (no)
ZA (1)	ZA200007514B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9813554D0 (en) *	1998-06-23	1998-08-19	Glaxo Group Ltd	Chemical compounds
JP5042425B2 (ja) *	2000-03-01	2012-10-03	ユーロセルティックソシエテアノニム	機能性胃腸疾患治療用トラマドール
US20040162422A1 (en) *	2001-03-20	2004-08-19	Adrian Hall	Chemical compounds
GB0106867D0 (en) *	2001-03-20	2001-05-09	Glaxo Group Ltd	Process
GB0115178D0 (en) *	2001-06-20	2001-08-15	Glaxo Group Ltd	Compounds
GB0115182D0 (en) *	2001-06-20	2001-08-15	Glaxo Group Ltd	Medicaments
US6946449B2 (en)	2001-07-13	2005-09-20	Cv Therapeutics, Inc.	Partial and full agonists of A1 adenosine receptors
US7713946B2 (en)	2002-07-11	2010-05-11	Cv Therapeutics, Inc.	Partial and full agonists A1 adenosine receptors
US7157440B2 (en)	2001-07-13	2007-01-02	Cv Therapeutics, Inc.	Partial and full agonists of A1 adenosine receptors
NZ534801A (en) *	2002-02-19	2006-04-28	Cv Therapeutics Inc	Partial and full agonists of A1 adenosine receptors
AU2003276996A1 (en) *	2002-06-17	2003-12-31	Glaxo Group Limited	Process for the preparation of heterocyclyl substituted adenosine derivatives
CA2495370A1 (en) *	2002-08-15	2004-02-26	Cv Therapeutics, Inc.	Partial and full agonists of a1 adenosine receptors
WO2004055032A1 (en) *	2002-12-18	2004-07-01	Glaxo Group Limited	Adenosine derivative in polymorph v form
AU2003292255A1 (en) *	2002-12-18	2004-07-09	Glaxo Group Limited	Polymorph
WO2004055033A1 (en) *	2002-12-18	2004-07-01	Glaxo Group Limited	Adenosine derivative in polymorph iv form
KR20050097971A (ko)	2003-02-03	2005-10-10	씨브이 쎄러퓨틱스, 인코포레이티드	Ａ₁아데노신 수용체의 부분 및 전 작용제
WO2005053712A1 (en) *	2003-12-02	2005-06-16	Glaxo Group Limited	Use of adenonsine derivatives for treating dyslipidemia, obesity, cardiovascular risk factors, metabolic syndrome, polycystic ovary syndrome, niddm
GT200500281A (es) *	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0500785D0 (en) *	2005-01-14	2005-02-23	Novartis Ag	Organic compounds
GB0607953D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
US8258141B2 (en)	2006-04-21	2012-09-04	Novartis Ag	Organic compounds
GB0607948D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607950D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607954D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
GB0607944D0 (en) *	2006-04-21	2006-05-31	Novartis Ag	Organic compounds
EP1889846A1 (en)	2006-07-13	2008-02-20	Novartis AG	Purine derivatives as A2a agonists
EP1903044A1 (en) *	2006-09-14	2008-03-26	Novartis AG	Adenosine Derivatives as A2A Receptor Agonists
KR20090087054A (ko) *	2006-11-10	2009-08-14	노파르티스 아게	시클로펜텐 디올 모노아세테이트 유도체
US20090088403A1 (en) *	2007-05-07	2009-04-02	Randy Blakely	A3 adenosine receptors as targets for the modulation of central serotonergic signaling
CN101712709A (zh)	2008-10-06	2010-05-26	中国医学科学院药物研究所	三乙酰基-3-羟基苯基腺苷及其调血脂的用途
CN107252433A (zh) *	2012-02-11	2017-10-17	中央研究院	治疗疼痛的方法及组合物
ES2792899T3 (es)	2015-02-24	2020-11-12	Pfizer	Derivados de nucleósidos sustituidos útiles como agentes anticancerosos
CN108864099A (zh) *	2018-09-08	2018-11-23	湖北荆洪生物科技股份有限公司	一种高纯6-糠氨基嘌呤的合成方法
EP4634186A1 (en)	2022-12-16	2025-10-22	Astrazeneca AB	2,6,9-trisubstituted purines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4962194A (en) *	1987-04-02	1990-10-09	Warner-Lambert Company	Method of preparing 51,N6-disubstituted adenosines from inosines
US5646128A (en) *	1989-09-15	1997-07-08	Gensia, Inc.	Methods for treating adenosine kinase related conditions
US5244896A (en) *	1990-09-14	1993-09-14	Marion Merrell Dow Inc.	Carbocyclic adenosine analogs useful as immunosuppressants
DK62592D0 (no) *	1992-05-14	1992-05-14	Novo Nordisk As
GB9301000D0 (en) *	1993-01-20	1993-03-10	Glaxo Group Ltd	Chemical compounds
AU683287B2 (en) *	1993-07-23	1997-11-06	Merrell Pharmaceuticals Inc.	Novel 9-N-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
WO1998001459A1 (en) *	1996-07-05	1998-01-15	Novo Nordisk A/S	Novel n-alkoxyadenine derivatives acting as cytokine inhibitors
UA51716C2 (uk) *	1996-07-08	2002-12-16	Авентіс Фармасьютікалз Продактс Інк.	Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування
AU4377397A (en)	1996-10-14	1998-05-11	Novo Nordisk A/S	Novel therapeutically active adenosine derivatives
TW528755B (en) *	1996-12-24	2003-04-21	Glaxo Group Ltd	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (sh)	1998-01-31	2003-01-31	Glaxo Group Limited	Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
PE20000270A1 (es)	1998-02-14	2000-05-20	Glaxo Group Ltd	Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol
GB9813554D0 (en) *	1998-06-23	1998-08-19	Glaxo Group Ltd	Chemical compounds

1998
- 1998-06-23 GB GBGB9813554.4A patent/GB9813554D0/en not_active Ceased
1999
- 1999-06-21 EP EP99927999A patent/EP1090019B1/en not_active Expired - Lifetime
- 1999-06-21 AU AU45146/99A patent/AU758018B2/en not_active Ceased
- 1999-06-21 JP JP2000555913A patent/JP3378240B2/ja not_active Expired - Lifetime
- 1999-06-21 US US09/736,018 patent/US6492348B1/en not_active Expired - Lifetime
- 1999-06-21 ES ES99927999T patent/ES2226399T3/es not_active Expired - Lifetime
- 1999-06-21 RS YUP-828/00A patent/RS50042B/sr unknown
- 1999-06-21 PT PT99927999T patent/PT1090019E/pt unknown
- 1999-06-21 ID IDW20010186A patent/ID27484A/id unknown
- 1999-06-21 HR HR20000896A patent/HRP20000896B1/xx not_active IP Right Cessation
- 1999-06-21 PE PE1999000547A patent/PE20000704A1/es not_active Application Discontinuation
- 1999-06-21 WO PCT/EP1999/004182 patent/WO1999067262A1/en not_active Ceased
- 1999-06-21 AT AT99927999T patent/ATE277941T1/de not_active IP Right Cessation
- 1999-06-21 PL PL99345089A patent/PL194087B1/pl unknown
- 1999-06-21 SK SK1958-2000A patent/SK19582000A3/sk unknown
- 1999-06-21 SI SI9930674T patent/SI1090019T1/xx unknown
- 1999-06-21 MY MYPI99002543A patent/MY122481A/en unknown
- 1999-06-21 DE DE69920697T patent/DE69920697T2/de not_active Expired - Lifetime
- 1999-06-21 BR BR9911498-4A patent/BR9911498A/pt not_active Application Discontinuation
- 1999-06-21 GE GEAP19995692A patent/GEP20032958B/en unknown
- 1999-06-21 EE EEP200000784A patent/EE04853B1/xx not_active IP Right Cessation
- 1999-06-21 EA EA200001222A patent/EA003828B1/ru not_active IP Right Cessation
- 1999-06-21 TR TR2001/00449T patent/TR200100449T2/xx unknown
- 1999-06-21 UA UA2000127404A patent/UA64794C2/uk unknown
- 1999-06-21 IL IL14028499A patent/IL140284A0/xx active IP Right Grant
- 1999-06-21 CN CNA2004100119394A patent/CN1616459A/zh active Pending
- 1999-06-21 EP EP04076465A patent/EP1447407A1/en not_active Withdrawn
- 1999-06-21 NZ NZ508915A patent/NZ508915A/en unknown
- 1999-06-21 CA CA002335520A patent/CA2335520C/en not_active Expired - Fee Related
- 1999-06-21 HU HU0102453A patent/HUP0102453A3/hu unknown
- 1999-06-21 KR KR1020007014749A patent/KR100612797B1/ko not_active Expired - Fee Related
- 1999-06-21 AP APAP/P/2000/002014A patent/AP2000002014A0/en unknown
- 1999-06-21 CN CNB998098957A patent/CN1202118C/zh not_active Expired - Fee Related
- 1999-06-21 CO CO99038539A patent/CO5040216A1/es unknown
- 1999-06-21 OA OA1200000352A patent/OA11574A/en unknown
- 1999-06-22 AR ARP990102993A patent/AR018917A1/es unknown
- 1999-07-01 TW TW088111178A patent/TW541312B/zh not_active IP Right Cessation
2000
- 2000-12-13 IL IL140284A patent/IL140284A/en not_active IP Right Cessation
- 2000-12-14 ZA ZA200007514A patent/ZA200007514B/en unknown
- 2000-12-15 IS IS5773A patent/IS5773A/is unknown
- 2000-12-20 NO NO20006520A patent/NO318788B1/no unknown
2001
- 2001-01-15 BG BG105155A patent/BG65064B1/bg unknown
2002
- 2002-06-11 JP JP2002170486A patent/JP2003040891A/ja active Pending
- 2002-08-13 US US10/217,107 patent/US6677316B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
YU82800A (sh)	2003-04-30
JP3378240B2 (ja)	2003-02-17
PL345089A1 (en)	2001-12-03
EA200001222A1 (ru)	2001-08-27
AU4514699A (en)	2000-01-10
SI1090019T1 (en)	2005-02-28
JP2003040891A (ja)	2003-02-13
PE20000704A1 (es)	2000-08-03
TW541312B (en)	2003-07-11
DE69920697D1 (de)	2004-11-04
WO1999067262A1 (en)	1999-12-29
MY122481A (en)	2006-04-29
GEP20032958B (en)	2003-04-25
HUP0102453A2 (hu)	2002-04-29
AR018917A1 (es)	2001-12-12
ZA200007514B (en)	2002-01-23
CN1202118C (zh)	2005-05-18
KR100612797B1 (ko)	2006-08-17
NO318788B1 (no)	2005-05-09
ATE277941T1 (de)	2004-10-15
PT1090019E (pt)	2005-01-31
EP1090019B1 (en)	2004-09-29
HK1034978A1 (en)	2001-11-09
CO5040216A1 (es)	2001-05-29
US20030096788A1 (en)	2003-05-22
EE200000784A (et)	2002-04-15
HRP20000896B1 (en)	2006-03-31
ES2226399T3 (es)	2005-03-16
ID27484A (id)	2001-04-12
EE04853B1 (et)	2007-06-15
OA11574A (en)	2004-07-21
IS5773A (is)	2000-12-15
PL194087B1 (pl)	2007-04-30
HRP20000896A2 (en)	2001-12-31
GB9813554D0 (en)	1998-08-19
EP1090019A1 (en)	2001-04-11
US6677316B2 (en)	2004-01-13
JP2002518509A (ja)	2002-06-25
IL140284A0 (en)	2002-02-10
NZ508915A (en)	2003-09-26
IL140284A (en)	2006-04-10
DE69920697T2 (de)	2005-02-24
SK19582000A3 (sk)	2001-11-06
NO20006520L (no)	2001-02-14
BG65064B1 (bg)	2007-01-31
US6492348B1 (en)	2002-12-10
CN1616459A (zh)	2005-05-18
CA2335520A1 (en)	1999-12-29
KR20010083067A (ko)	2001-08-31
AU758018B2 (en)	2003-03-13
CN1314910A (zh)	2001-09-26
UA64794C2 (en)	2004-03-15
EP1447407A1 (en)	2004-08-18
HUP0102453A3 (en)	2002-10-28
BG105155A (en)	2001-09-28
CA2335520C (en)	2007-02-20
RS50042B (sr)	2008-11-28
TR200100449T2 (tr)	2001-08-21
AP2000002014A0 (en)	2000-12-31
BR9911498A (pt)	2001-03-20
EA003828B1 (ru)	2003-10-30

Publication	Publication Date	Title
NO20006520D0 (no)	2000-12-20	Adenosinderivater
DE69937850D1 (de)	2008-02-14	Hautablationslaser
DE69917956D1 (de)	2004-07-22	Tintenzuführsystemadapter
ATE341990T1 (de)	2006-11-15	Sigmidoskop
DE69940487D1 (de)	2009-04-09	Fluidumverdichter
DE69911432D1 (de)	2003-10-23	Abgasrückfürungseinrichtung
FI980132A0 (fi)	1998-01-21	Adapterande efterfilter
DE69909757D1 (de)	2003-08-28	Ethylencopolymerisationsverfahren
DE69940286D1 (de)	2009-03-05	Brenstoffzellenstapel
DE69925611D1 (de)	2005-07-07	Stopfbüchsenvorrichtung
DE69929317D1 (de)	2006-03-30	Endanschlagregelungsverfahren
FI20002715L (fi)	2000-12-11	Kaiuttimet
DE69812868D1 (de)	2003-05-08	Flanschreformierungsanlage
DE69933673D1 (de)	2006-11-30	Polyurethandispergiermittel
DE69937642D1 (de)	2008-01-10	Trimaranstruktur
DE69911779D1 (de)	2003-11-06	Polymergelelektrode
DE69901068D1 (de)	2002-05-02	Estersynthese
DE69901852D1 (de)	2002-07-25	Perfluorodioxolen
DE69919644D1 (de)	2004-09-30	Wellenabstreifdichtung
DE69926706D1 (de)	2005-09-22	Niederdruckquecksilberdampfeentladungslampe
NO20011358L (no)	2001-04-17	Antivirale kombinasjoner
EA199900675A3 (ru)	2000-06-26	Полиморф моногидрата зополрестата
FI980187A0 (fi)	1998-01-28	Vattenturbinsystem
DE59808995D1 (de)	2003-08-14	Endomikroskopsystem
PT1076660E (pt)	2002-11-29	(4-bromopirazol-3-il)-benzazolos substituidos